| HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A. | |
| | |
MedLine Citation:
|
PMID: 20455727 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Increasing evidence indicates that statins increase peritoneal fibrinolysis through RhoA-linked pathway and may play a role in the prevention of postoperative adhesion. This study investigated whether lovastatin perturbs cytoskeletons and cell morphology by RhoA suppression in peritoneal Met5A cells. Subcellular distributions of RhoA protein and actin were assessed by immunocytochemical staining. Exposure to lovastatin caused actin filament reorganisation, decrease in the active (membrane-bound) form of RhoA and subsequently cellular shrinkage in Met5A cells. These lovastatin-induced changes were significantly overcome by the addition of geranylgeranyl pyrophosphate (downstream intermediate of HMG-CoA pathway). A RhoA protein inhibitor C3 transferase mimicked the effects of lovastatin on the Met5A cells. The effects of lovastatin on cytoskeleton alterations were correlated well with inhibition of the membrane localisation of RhoA. These results suggest that lovastatin induced reversible cytoskeleton reorganisation and cellular retraction through the reduction of RhoA geranylgeranylation, which in turn suppressed RhoA signalling-associated cellular events. |
| | |
Authors:
|
N Suzuki; A Imai |
Related Documents
:
|
22629227 - Cyclin d1 expression and its correlation with histopathological differentiation in oral... 19417107 - Bacterial intermediate filaments: in vivo assembly, organization, and dynamics of cresc... 19520607 - 2d and 3d cell microarrays in pharmacology. 18075997 - The hidden side of the prokaryotic cell: rediscovering the microbial world. 17274977 - Diffusion analysis of glucocorticoid receptor and antagonist effect in living cell nucl... 2547957 - Mucosal epithelial cells and langerhans cells are targets for infection by the immunosu... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology Volume: 30 ISSN: 1364-6893 ISO Abbreviation: J Obstet Gynaecol Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-11 Completed Date: 2010-08-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8309140 Medline TA: J Obstet Gynaecol Country: England |
Other Details:
|
Languages: eng Pagination: 404-7 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cell Line Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology* Lovastatin / pharmacology* Microfilaments / drug effects* Peritoneal Diseases / metabolism* Plasminogen Inactivators / metabolism Signal Transduction / drug effects Tissue Adhesions / metabolism rhoA GTP-Binding Protein / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Plasminogen Inactivators; 75330-75-5/Lovastatin; EC 3.6.5.2/rhoA GTP-Binding Protein |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The use of an integrated care pathway for evidence-based practice and clinical governance in abortio...
Next Document: A rare cause of postpartum headache.